The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population
Abstract
BACKGROUND The administration of aspirin <16 weeks' gestation to high risk women for preeclampsia (PE) has been shown to reduce the rate of preterm PE by 65%. The traditional approach to identify such women at risk is based on risk factors from maternal characteristics, obstetrics, and medical history as recommended by the American College of Obstetricians and Gynecologists (ACOG) and the National Institute for Health and Care Excellence (NICE). An alternative approach to screening for PE has been developed by the Fetal Medicine Foundation (FMF). This approach allows estimation of patient-specific risks of PE requiring delivery before a specified gestational age with the use of Bayes theorem-based model. OBJECTIVE To examine the diagnostic accuracy of the FMF Bayes theorem-based model, the ACOG and the NICE recommendations for the prediction of preterm PE at 11-13+6 weeks' gestation in a large Asian population METHODS: This was a prospective, non-intervention, multicenter study in 10,935 singleton pregnancies at 11-13+6 weeks' gestation in 11 recruiting centers across seven regions in Asia between December 2016 and June 2018. Maternal characteristics, medical, obstetric, and drug history were recorded. Mean arterial pressure (MAP) and uterine artery pulsatility index (UtA-PI) were measured according to standardized protocols. Maternal serum placental growth factor (PlGF) concentrations were measured by automated analyzers. The measured values of MAP, UtA-PI, and PlGF were converted into multiple of medians (MoMs). The FMF Bayes theorem-based model was used for the calculation of patient-specific risk of PE at <37 weeks (preterm PE) and at any gestation (all PE) in each participant. The performance of screening for preterm PE and all PE by a combination of maternal factors, MAP, UtA-PI, and PlGF (triple test) was evaluated with the adjustment of aspirin use. We examined the predictive performance of the model by the use of receiver operating characteristic curve and calibration by measurements of calibration slope and calibration-in-the large. The detection rate of screening by the FMF Bayes theorem-based model was compared to that derived from the application of ACOG and NICE recommendations. RESULTS There were 224 (2.05%) women that developed PE, including 73 cases (0.67%) of preterm PE. In pregnancies with preterm PE, the mean MoM values of MAP and UtA-PI were significantly higher (MAP: 1.099 vs. 1.008; p<0.001; UtA-PI: 1.188 vs 1.063; p=0.006), and the mean PlGF MoM was significantly lower (0.760 vs. 1.100; p<0.001) than in women without PE. The FMF triple test achieved detection rates of 48.2%, 64.0%, 71.8% and 75.8%, at 5%, 10%, 15% and 20% fixed false-positive rates, respectively, for the prediction of preterm PE. These were comparable to those of previously published data from the FMF study. Screening using ACOG recommendations achieved detection rate of 54.6% at 20.4% false-positive rate. The detection rate with the use of NICE guideline was 26.3% at 5.5% false-positive rate. CONCLUSION Based on a large number of women, this study has demonstrated that the FMF Bayes theorem-based model is effective in predicting preterm PE in Asian population and this method of screening is superior to the approach recommended by ACOG and NICE. We have also shown that the FMF prediction model can be implemented as part of routine prenatal care through the use of the existing infrastructure of routine prenatal care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704559 · Cited by 2,287
Self-citationACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002708 · Cited by 711
External validation is necessary in prediction research:
Bleeker, S. E., Moll, H. A., Steyerberg, E. W., Donders, A. R. T., Derksen-Lubsen, G., Grobbee, D. E., & Moons, K. G. M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00207-5 · Cited by 710
Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.076 · Cited by 679
O’Gorman, N., Wright, D., Syngelaki, A., Akolekar, R., Wright, A., Poon, L. C., & Nicolaides, K. H. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.034 · Cited by 629
Self-citationAspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis
Roberge, S., Bujold, E., & Nicolaides, K. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.561 · Cited by 628
Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation
Tan, M. Y., Syngelaki, A., Poon, L. C., Rolnik, D. L., O'Gorman, N., Delgado, J. L., Akolekar, R., Konstantinidou, L., Tsavdaridou, M., Galeva, S., et al. (2018) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.19112 · Cited by 438
Self-citationUterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre‐eclampsia
Plasencia, W., Maiz, N., Bonino, S., Kaihura, C., & Nicolaides, K. H. (2007) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5157 · Cited by 425
Ye, C., Ruan, Y., Zou, L., Li, G., Li, C., Chen, Y., Jia, C., Megson, I. L., Wei, J., & Zhang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100180 · Cited by 221
Cited by
Magee, L. A., Brown, M. A., Hall, D. R., Gupte, S., Hennessy, A., Karumanchi, S. A., Kenny, L. C., McCarthy, F., Myers, J., Poon, L. C., et al. (2022) · Pregnancy Hypertension · doi:10.1016/j.preghy.2021.09.008 · Cited by 1,134
Self-citationPrevention of preeclampsia with aspirin
Rolnik, D. L., Nicolaides, K. H., & Poon, L. C. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.08.045 · Cited by 390
Self-citationFirst trimester preeclampsia screening and prediction
Chaemsaithong, P., Sahota, D. S., & Poon, L. C. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.07.020 · Cited by 363
Self-citationMalone, S. L., Haj Yahya, R., & Kane, S. C. (2022) · International Journal of Women's Health · doi:10.2147/ijwh.s283239 · Cited by 32
Metadata
- Authors
- Chaemsaithong, P., Pooh, R. K., Zheng, M., Ma, R., Chaiyasit, N., Tokunaka, M., Shaw, S. W., Seshadri, S., Choolani, M., Wataganara, T., Yeo, G. S. H., Wright, A., Leung, W. C., Sekizawa, A., Hu, Y., Naruse, K., Saito, S., Sahota, D., Leung, T. Y., & Poon, L. C.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 221
- Issue
- 6
- Pages
- 650.e1-650.e16
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W2978654833
- Cited by
- 169
- References
- 12
- FWCI
- 13.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. https://app.cochat.ai/papers/10.1016/j.ajog.2019.09.041
- The paper
- Chaemsaithong, P., Pooh, R. K., Zheng, M., Ma, R., Chaiyasit, N., Tokunaka, M., Shaw, S. W., Seshadri, S., Choolani, M., Wataganara, T., Yeo, G. S. H., Wright, A., Leung, W. C., Sekizawa, A., Hu, Y., Naruse, K., Saito, S., Sahota, D., Leung, T. Y., & Poon, L. C. (2019). Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2019.09.041
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.